Insurers Must Pay Pharma Co. Defense Costs In SEC Probe

A drug development company formed by a merger is entitled to insurance payments for expenses it paid two of its former officers in connection with federal subpoenas because the insurer failed...

Already a subscriber? Click here to view full article